Skip to content
MENU
Rewind Therapeutics
Rewind Therapeutics
Rewind Therapeutics
Rewind Therapeutics
Rewind Therapeutics Rewind Therapeutics
  • Home
  • Approach & Pipeline
  • Scientific Background
  • Team
  • News & Events
  • Careers
  • Investors & Partners
  • Contact
  • Home
  • Approach & Pipeline
  • Scientific Background
  • Team
  • News & Events
  • Careers
  • Investors & Partners
  • Contact
© 2022 Rewind Therapeutics. All rights reserved.
MENU
  • Home
  • Approach & Pipeline
  • Scientific Background
  • Team
  • News & Events
  • Careers
  • Investors & Partners
  • Contact
linkedin

News & Events

Latest News

June 18, 2025

Rewind Therapeutics Strengthens Scientific Advisory Board

January 25, 2023

Rewind Therapeutics Raises Additional Funding and Adds Sunstone Life Science Ventures A/S as New Investor

November 29, 2022

Rewind Therapeutics Appoints Dr. Stephen Burbidge to its Management Team

October 19, 2022

ECTRIMS 2022, October 26-28, Amsterdam, The Netherlands

October 18, 2022

Rewind Therapeutics Appoints Irene Knuesel, PhD, as Chief Scientific Officer

September 22, 2021

Rewind Therapeutics appoints Anja Harmeier, PhD, MBA, as Chief Executive Officer

September 2, 2020

Rewind Therapeutics appoints Kees Been as Non-Executive Director

Upcoming Events

May 3, 2023

BIO International Convention, June 5-8, 2023, Boston, MA, USA

May 3, 2023

Bio€quity Europe, May 14-16, 2023, Dublin, Ireland

August 24, 2022

BIO Europe, October 24-26, Leipzig, Germany

If you have any questions
please contact us

Contact Us
  • Rewind Therapeutics
  • Rewind Therapeutics
    Gaston Geenslaan 3
    3001 Leuven, Belgium
    VAT BE 0682 626 216

    • Privacy Policy
linkedin
© 2025 Rewind Therapeutics. All rights reserved.